News and Updates

CMS Code G0680 opens doors to AI-enabled opportunistic detection of patients with silent coronary artery disease who are unaware of their risk of a future heart attack. HOUSTON, April 7, 2026 -- HeartLung AI today welcomed CMS’s establishment of HCPCS code G0680 in the April 2026 Hospital Outpatient Prospective Payment System update, effective April 1, 2026, for algorithmic analysis of coronary artery calcium (CAC) and/or aortic valve calcification from chest CT with report.

HeartLung.AI today announced that it will showcase seven scientific presentations at ACC.26, the American College of Cardiology’s 75th Annual Scientific Session & Expo, taking place next weekend in New Orleans. HeartLung is the only company in the entire cardiovascular industry exhibit hall that has seven accepted scientific presentations at ACC Scientific Sessions. HeartLung will exhibit at Booth 109 and will present new data spanning atrial fibrillation, heart failure, str

Houston, TX – [March 18, 2026] – HeartLung Technologies today announced strong support for the newly released 2026 ACC/AHA Multisociety Guideline on the Management of Dyslipidemia, which introduces a major paradigm shift in cardiovascular prevention: the formal recognition of opportunistic detection of coronary artery calcium (CAC) on routine noncardiac CT scans, including the use of validated artificial intelligence algorithms. For the first time, leading cardiovascular soci

AutoChamber™ and AutoBMD™ AI solutions will soon be available on Precision Imaging Network, with AI-CVD® planned next. HOUSTON, TX, UNITED STATES, February 3, 2026 -- HeartLung.AI , an AI-enabled company focused on early detection and prevention of heart disease, lung cancer, osteoporosis, emphysema and fatty liver disease using widely available CT scans, announced that its AutoChamber™ and AutoBMD™ AI services will be available through Precision Imaging Network, part of Mic